Editorial: Angiogenesis and tumor metastasis

Qiang-Zhe Zhang; Yi-Pan Zhu; Michal A Rahat; Julia Kzhyshkowska

doi:10.3389/fonc.2022.1129736

Editorial: Angiogenesis and tumor metastasis

Front Oncol. 2023 Jan 17:12:1129736. doi: 10.3389/fonc.2022.1129736. eCollection 2022.

Authors

Qiang-Zhe Zhang¹, Yi-Pan Zhu¹, Michal A Rahat², Julia Kzhyshkowska^{3

4

5}

Affiliations

¹ State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China.
² Immunotherapy Laboratory, Carmel Medical Center, and the Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
³ Institute of Transfusion Medicine and Immunology, Mannheim Institue for Innate Immunosciences (MI3), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
⁴ German Red Cross Blood Service Baden-Württemberg - Hessen, Mannheim, Germany.
⁵ Laboratory for Translational Cellular and Molecular Biomedicine, Tomsk State University, Tomsk, Russia.

No abstract available

Keywords: EMT; EndoMT; angiogenesis; biomarker; tumor metastasis.

Publication types

Editorial

Grants and funding

This work was supported by the National Natural Science Foundation of China (No. 82073233), Israel Science Foundation (ISF) grant number 2607/20, the state contract of the Ministry of Science and Higher Education of the Russian Federation “Genetic and epigenetic editing of tumor cells and microenvironment in order to block metastasis” o. 075-15-2021-1073 and Tomsk State University Development Programme (Priority 20-30).